- The Gap Between Laboratory and Field Performance
- What Biopesticide Formulation Must Actually Do
- Incapsulex: Microencapsulation as a Formulation Platform
- Adhesulex: Delivery and Deposition as a Formulation Platform
- Why Formulation Technology Is a Commercial Differentiator
- The Broader Platform Picture
- FAQs
Biological crop protection has a performance problem that rarely gets discussed honestly. A biopesticide active can show strong results under controlled conditions and still produce inconsistent outcomes in the field. When that happens, the instinct is to question the biology. Often, the real issue is the formulation.
Formulation is not packaging. It is not a finishing step applied after the science is done. For biological actives, formulation determines whether the organism survives manufacturing, storage, application, and contact with the target environment. It determines whether the active reaches the pest at the right concentration, at the right time, in a viable state. Get the formulation wrong, and the biology is irrelevant.
This article explains why biopesticide formulation is a core determinant of field efficacy, what specific challenges it must solve, and how Bionema's proprietary platforms — Incapsulex and Adhesulex — address those challenges under commercial conditions.
The Gap Between Laboratory and Field Performance
A biological active that performs well in a controlled trial can fail to replicate that performance at commercial scale for several interconnected reasons.
Biological actives are living organisms or biologically derived compounds. They are sensitive to temperature fluctuations, UV radiation, desiccation, pH, and the chemical environment of the spray tank. A fungal spore that is viable in a laboratory culture may lose viability during formulation processing, during storage, or within minutes of application to a sun-exposed leaf surface.
They also need to reach their target. A nematode or fungal spore applied to foliage that dries before the active can penetrate or persist achieves nothing. A microbial inoculant applied to soil that cannot establish in the rhizosphere will not deliver the plant health benefit it was designed for.
And field conditions are variable. Temperature, humidity, crop canopy architecture, soil type, and application equipment all affect how a formulated product behaves. A formulation engineered only for ideal conditions will produce inconsistent results across real-world applications.
This gap between laboratory and field performance is sometimes called the biological efficacy gap. Closing it is primarily a formulation challenge, not a biology challenge.
What Biopesticide Formulation Must Actually Do
Designing a formulation for a biological active means solving several problems at once.
Protect the active during storage and transit. Most biological actives have a shorter shelf life than synthetic chemistry. Formulation must extend viable shelf life without compromising activity — typically by controlling moisture, oxygen exposure, and temperature sensitivity through encapsulation or protective carrier systems.
Protect the active during and after application. UV degradation is one of the most significant causes of field performance loss in fungal biopesticides. A spore exposed to direct sunlight on a leaf surface may lose viability within hours. Formulation must shield the active during the critical window between application and pest contact.
Ensure target delivery. The active needs to reach the pest, not simply the crop surface. That requires formulation engineering that controls droplet size, spreading behaviour, adhesion to target surfaces, and persistence in the application zone. A product that runs off or evaporates before the active can act is commercially useless regardless of the biology.
Control release timing. Some biological actives are most effective when released gradually rather than all at once. Controlled release formulation allows the active to be deployed over an extended period — particularly relevant for soil-applied products where the target pest or pathogen is encountered across a longer time window.
Maintain compatibility. Biological actives are often applied alongside other inputs: adjuvants, nutrients, or other crop protection products. Formulation must ensure the active remains viable in the spray tank and does not interact adversely with other components.
Each of these requirements demands formulation science specific to biological actives. Approaches developed for synthetic chemistry do not transfer directly, because the constraints are fundamentally different.
Incapsulex: Microencapsulation as a Formulation Platform
Bionema's Incapsulex platform addresses the protection and controlled release challenges through microencapsulation. Designed specifically for biological actives, it provides a protective shell around the organism or compound that shields it from environmental degradation while allowing controlled release under defined conditions.
Microencapsulation does several things that conventional formulation approaches cannot. It physically separates the active from the external environment during storage and transit, extending viable shelf life. It protects fungal spores and other sensitive actives from UV exposure and desiccation after application. And it allows the release profile to be engineered, so the organism or compound is deployed at the point and time where it is most effective.
For a fungal biopesticide like Metar101, the formulation challenge is significant. Fungal spores are sensitive to UV, temperature, and moisture. Without effective encapsulation, the viability window after application is narrow. Incapsulex is designed to extend that window, giving the spore the protection it needs to remain viable until it contacts the target pest.
The commercial implication is straightforward. A biological active with strong intrinsic efficacy, protected by a formulation platform engineered for stability and controlled release, is a more reliable product. Reliability is what distribution partners need to build commercial confidence, and what end users need to justify integrating a biological into their IPM programme.
Adhesulex: Delivery and Deposition as a Formulation Platform
Protecting the active is necessary but not sufficient. It also needs to reach the target surface and stay there long enough to act. That is the problem Adhesulex is designed to solve.
Adhesulex is a formulation and delivery platform focused on spreading, adhesion, deposition, and target delivery. In practical terms, it controls how a formulated product behaves when it contacts a leaf surface, soil particle, or other application substrate — managing droplet behaviour, surface wetting, and the adhesion of the active to the target zone.
The relevance to biological efficacy is direct. A biological active that fails to adhere to the target surface, or that is washed off by rain or irrigation before it can act, will not deliver consistent field performance. Adhesulex addresses the delivery side of the formulation equation, ensuring the active is deposited where it needs to be and remains there through the conditions it will encounter in the field.
This matters particularly in turf and amenity applications, where the target zone is often the thatch layer or soil surface and where irrigation or rainfall is a regular variable. It also matters in horticultural applications where leaf architecture can make uniform coverage technically demanding.
Why Formulation Technology Is a Commercial Differentiator
For distribution and commercial partners evaluating a biological product line, formulation quality is fundamentally a risk management question. A product with inconsistent field performance generates technical complaints, damages commercial relationships, and undermines confidence in the biologicals category as a whole. A product backed by formulation platforms specifically engineered for biological actives is a lower-risk commercial proposition.
For technology and licensing partners, formulation capability signals something different: that the company can take a biological active and make it work reliably at commercial scale. That is the fundamental requirement for a licensable product. The fact that Syngenta Crop Protection acquired two Bionema products and supporting technology in 2021 is relevant context here. That transaction confirmed the formulation and technology met the evaluation standards of a Tier-1 agrochemical company — a meaningful indicator of commercial-grade capability.
Formulation also determines regulatory viability. A biological active that cannot be formulated for consistent stability, safety, and performance cannot be registered. Formulation is embedded in the regulatory dossier, not separate from it.
The Broader Platform Picture
Incapsulex and Adhesulex are two of Bionema's named formulation and delivery platforms. The third, BiofilmTech, addresses a different but related challenge: establishing and maintaining microbial activity in the root zone. Together, these platforms reflect an approach to biological crop protection in which formulation is treated as a primary determinant of efficacy, not a secondary consideration.
Bionema operates across agriculture, horticulture, turf and amenity, forestry, and public health — a breadth of application environments that spans a wide range of target pests, delivery requirements, and field conditions. A platform developed to protect a fungal biopesticide in a turf application must perform differently from one designed for a soil-applied biostimulant in arable. That range of real-world demands has shaped the formulation science.
For agronomists, growers, and turf managers, the practical takeaway is this: when evaluating a biological product, the formulation question is as important as the biology question. Asking how the active is protected, how it is delivered, and what the evidence base looks like for field performance under your specific conditions will tell you more about likely outcomes than the label claim alone.
FAQs
What is biopesticide formulation and why does it matter?
Biopesticide formulation is the process of preparing a biological active for commercial use — protecting it during storage and transit, ensuring it reaches the target pest in a viable state, and controlling how it behaves after application. Formulation directly affects whether a biological active performs consistently in field conditions, making it a core component of efficacy rather than a secondary packaging step.
What is the biological efficacy gap?
The biological efficacy gap describes the difference between a biological active's performance under controlled conditions and its performance in commercial field applications. The gap is primarily a formulation challenge: without the right protection, delivery, and release mechanisms, even a highly effective organism can fail to perform reliably in variable field environments.
What does Incapsulex do?
Incapsulex is Bionema's microencapsulation platform. It protects biological actives from environmental degradation — including UV exposure and desiccation — during storage and after application. It also enables controlled release, allowing the organism or compound to be deployed at the point and time where it is most effective.
What does Adhesulex do?
Adhesulex is Bionema's formulation and delivery platform focused on spreading, adhesion, deposition, and target delivery. It controls how a formulated product behaves on contact with the target surface, ensuring the active is deposited where it needs to be and remains there through field conditions such as rain or irrigation.
How does formulation affect the shelf life of a biological product?
Biological actives are sensitive to temperature, moisture, and oxygen. Without effective formulation, viable shelf life is short and variable. Microencapsulation and protective carrier systems extend shelf life by physically separating the active from environmental stressors — essential for commercial supply chains that require consistent product quality over time.
Why should distribution partners care about formulation platforms?
Distribution partners carry commercial risk when they add a biological product to their portfolio. A product with inconsistent field performance generates technical complaints and erodes grower confidence. A product backed by formulation platforms engineered specifically for biological actives is more likely to deliver repeatable results, reducing commercial risk and supporting long-term portfolio performance.
How does formulation capability relate to technology licensing?
For licensing and co-development partners, formulation capability is evidence that a biological active can be taken from the laboratory to commercial scale reliably. Formulation is embedded in the regulatory dossier and is a prerequisite for registration. A company with proprietary formulation platforms validated through commercial transactions — including Tier-1 agrochemical evaluation — offers a more complete and lower-risk technology package than one offering biological actives without formulation infrastructure.
Formulation is where biological science becomes a commercial product. If you are evaluating biological actives, building a biologicals portfolio, or looking for formulation technology that can make a biological active perform reliably in the field, the formulation platform behind the product is the right place to start your assessment. Learn more at bionema.com.
